Micromedic sign a non-binding memorandum of understanding

BioLight (“the Company”) hereby announce that on March 25, 2019, according to the immediate report of Micromedic Technologies Ltd. (“Micromedic”), an investee company controlled by the Company, Micromedic entered into a non-binding memorandum of understanding with Nexstage Cannabis Innovation Ltd. (“Nexstage”, for information on Nexstage, see Section 6 of the Micromedic Report) and with the shareholders of Nexstage (the “Non-binding MOU”), under which, subject to the signing of a detailed agreement between the parties and the fulfillment of preconditions, a merger transaction will be executed between Micromedic and Nexstage (“The merger transaction”).


Link to the complete article

Link to Newsroom

Comments are closed.